AKBA
#3476
Akebia Therapeutics, Inc. - Common Stock
0.8 1 USD
-0.07%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-6.90%
Monthly Change
-14.74%
6 month change
-42.55%
Year Change
-31.36%
Previous Close
0.8 7
Open
0.8 5
Low
0.8 1
High
0.8 6
Financials
2022
Current report, 30 Jun 2022
Akebia Therapeutics, Inc. current report, 30 June 2022
8-K
Current report, 06 Jun 2022
Akebia Therapeutics, Inc. current report, 06 June 2022
8-K
Current report, 12 May 2022
Akebia Therapeutics, Inc. current report, 12 May 2022
8-K
Current report, 09 May 2022
Akebia Therapeutics, Inc. current report, 09 May 2022
8-K
Current report, 07 Apr 2022
Akebia Therapeutics, Inc. current report, 07 April 2022
8-K
Current report, 01 Apr 2022
Akebia Therapeutics, Inc. current report, 01 April 2022
8-K
Quarterly report, Q1 FY2022
Akebia Therapeutics, Inc. quarterly report, Q1 FY2022
10-Q
Current report, 30 Mar 2022
Akebia Therapeutics, Inc. current report, 30 March 2022
8-K
Current report, 01 Mar 2022
Akebia Therapeutics, Inc. current report, 01 March 2022
8-K
Current report, 18 Feb 2022
Akebia Therapeutics, Inc. current report, 18 February 2022
8-K